| 0 (0%) | 09-27 11:13 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 137.99 | 1-year : | 150.36 |
| Resists | First : | 118.14 | Second : | 128.74 |
| Pivot price | 116.04  |
|||
| Supports | First : | 101 | Second : | 84.03 |
| MAs | MA(5) : | 118.17 |
MA(20) : | 114.11 |
| MA(100) : | 120.71 |
MA(250) : | 97.89 |
|
| MACD | MACD : | 0.2 |
Signal : | 0 |
| %K %D | K(14,3) : | 48.8 |
D(3) : | 60.4 |
| RSI | RSI(14): 45.8 |
|||
| 52-week | High : | 160.8 | Low : | 55 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TMDX ] has closed above bottom band by 40.0%. Bollinger Bands are 21.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 115.08 - 115.89 | 115.89 - 116.5 |
| Low: | 110 - 111.09 | 111.09 - 111.92 |
| Close: | 112.35 - 113.84 | 113.84 - 114.98 |
Fri, 26 Sep 2025
Voya Investment Management LLC Sells 2,890 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Thu, 25 Sep 2025
TMDX Partners With Mercedes-Benz to Launch Organ Transport Network - Zacks Investment Research
Thu, 25 Sep 2025
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Wed, 24 Sep 2025
Here's Why TransMedics (TMDX) is a Strong Growth Stock - Yahoo Finance
Wed, 24 Sep 2025
Here's Why TransMedics (TMDX) is a Strong Growth Stock - Nasdaq
Tue, 23 Sep 2025
Silver Oak Securities Incorporated Purchases 2,823 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 34 (M) |
| Shares Float | 33 (M) |
| Held by Insiders | 3 (%) |
| Held by Institutions | 111.5 (%) |
| Shares Short | 8,270 (K) |
| Shares Short P.Month | 7,670 (K) |
| EPS | 1.99 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.35 |
| Profit Margin | 13.4 % |
| Operating Margin | 23.2 % |
| Return on Assets (ttm) | 5.8 % |
| Return on Equity (ttm) | 28.2 % |
| Qtrly Rev. Growth | 37.7 % |
| Gross Profit (p.s.) | 9.31 |
| Sales Per Share | 15.58 |
| EBITDA (p.s.) | 2.94 |
| Qtrly Earnings Growth | 162.5 % |
| Operating Cash Flow | 115 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | 57.22 |
| PEG Ratio | 0 |
| Price to Book value | 12.17 |
| Price to Sales | 7.3 |
| Price to Cash Flow | 33.67 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|